Sign In
Buy COWN
$38.99
+0 (+0%)
At Close: May 26, 2023
Skye Bioscience to Present at TD Cowen Health Care Conference
07:00am, Thursday, 20'th Feb 2025
SAN DIEGO, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obe
Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025
07:00am, Thursday, 20'th Feb 2025
CAMBRIDGE, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announce
Vir Biotechnology to Participate in TD Cowen 45th Annual Health Care Conference
04:05pm, Wednesday, 19'th Feb 2025
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that members of the executive team are scheduled to participate in a fireside chat at the TD Cowen 45th Annual Hea
PacBio to Participate in TD Cowen's 45th Annual Health Care Conference
04:05pm, Wednesday, 19'th Feb 2025
MENLO PARK, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenti
Tempus to Present at TD Cowen's 45th Annual Health Care Conference
08:30am, Wednesday, 19'th Feb 2025
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will present at the TD Cowen 45th Annual Health
Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference
08:00am, Wednesday, 19'th Feb 2025
MARLBOROUGH, Mass. , Feb. 19, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 45th Annual Health Care Conference on Tuesday, March 4, 2025.
Arcutis to Present at the TD Cowen 45th Annual Health Care Conference
04:35pm, Tuesday, 18'th Feb 2025
WESTLAKE VILLAGE, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in
Baxter to Present at TD Cowen 45th Annual Health Care Conference
04:15pm, Tuesday, 18'th Feb 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the TD Cowen 45th Annual Health Care Conference on Wednesday, March 5, 2025. Joel Grade
10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference
04:05pm, Tuesday, 18'th Feb 2025
PLEASANTON, Calif. , Feb. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate i
Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference
04:05pm, Tuesday, 18'th Feb 2025
SUNNYVALE, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with
Lilly to participate in TD Cowen's 45th Annual Health Care Conference
10:00am, Tuesday, 18'th Feb 2025
INDIANAPOLIS , Feb. 18, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in TD Cowen's 45th Annual Health Care Conference on March 4, 2025. Jake Van Naarden, executive vice pres
Mural Oncology to Present at the TD Cowen 45th Annual Health Care Conference
07:00am, Tuesday, 18'th Feb 2025
WALTHAM, Mass and DUBLIN, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered therapies targeting
Defense cuts wouldn't be a net negative for defense stocks, says TD Cowen's Roman Schweizer
02:01pm, Friday, 14'th Feb 2025
CNBC's Eamon Javers and TD Cowen's Roman Schweizer, join 'The Exchange' to discuss Trump's comments on halving defense spending and the impact it could have on defense stocks.
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference
08:55am, Tuesday, 11'th Feb 2025
EMERYVILLE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprie
SAN JOSE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative s
